If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Diane C Bodurka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Quality of Life Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology

Prescott, L. S., Taylor, J. S., Enbaya, A., Marten, C. A., Myers, K. N., Meyer, L. A., Ramirez, P. T., Levenback, C. F., Bodurka, D. C. & Schmeler, K. M., Jun 1 2019, In : Gynecologic oncology. 153, 3, p. 597-603 7 p.

Research output: Contribution to journalArticle

Blood Transfusion
Mortality
Incidence
Morbidity
Surgical Wound Infection

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study” (Gynecologic Oncology (2018) 151(1) (18–23), (S0090825818310850) (10.1016/j.ygyno.2018.07.021))

Olawaiye, A. B., Java, J. J., Krivak, T. C., Friedlander, M., Mutch, D. G., Glaser, G., Geller, M., O'Malley, D. M., Wenham, R. M., Lee, R. B., Bodurka, D. C., Herzog, T. J. & Bookman, M. A., Jan 2019, In : Gynecologic oncology. 152, 1, 1 p.

Research output: Contribution to journalComment/debate

Conflict of Interest
Adjuvant Chemotherapy
Ovarian Neoplasms
Financial Management
Consultants

How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients

Taylor, J. S., Zhang, N., Rajan, S. S., Chavez Mac Gregor, M., Zhao, H., Niu, J., Meyer, L. A., Ramondetta, L. M., Bodurka, D. C., Lairson, D. R. & Giordano, S. H., Mar 1 2019, In : Gynecologic oncology. 152, 3, p. 452-458 7 p.

Research output: Contribution to journalArticle

Hospices
Ovarian Neoplasms
Costs and Cost Analysis
Medicare
Hispanic Americans

Women's preferences for cancer risk management strategies in Lynch syndrome

Sun, C. C., Meyer, L. A., Daniels, M. S., Bodurka, D. C., Nebgen, D., Burton-Chase, A. M., Lu, K. H. & Peterson, S. K., Mar 1 2019, In : Gynecologic oncology. 152, 3, p. 514-521 8 p.

Research output: Contribution to journalArticle

Hereditary Nonpolyposis Colorectal Neoplasms
Risk Management
Visual Analog Scale
Neoplasms
Chemoprevention
4 Citations (Scopus)

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study

Olawaiye, A. B., Java, J. J., Krivak, T. C., Friedlander, M., Mutch, D. G., Glaser, G., Geller, M., O'Malley, D. M., Wenham, R. M., Lee, R. B., Bodurka, D. C., Herzog, T. J. & Bookman, M. A., Oct 2018, In : Gynecologic oncology. 151, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Ovarian Neoplasms
Carcinoma
Carboplatin
Granulocyte Colony-Stimulating Factor